Sony Corporation

Sony Mobile Communications Inc.

The Kitasato Institute

Keiko Sasaki

Satoshi Makino

Takayuki Mori

Masaharu Nakagawa

An image capturing apparatus is disclosed. An image capturing section captures an image of light and obtains image data. An image display section displays the image data obtained by the image capturing section with a predetermined number of pixels. A storage section stores the image data obtained by the image capturing section. An interface section is connectable to an external storage device. A control section causes the image data obtained by the image capturing section to be stored to the external storage device connected through the interface section, when the captured image data are stored to the external storage device, the image data whose number of pixel exceeds the predetermined number of pixels to be converted into image data having the predetermined number of pixels, and the converted image data to be stored to the storage section.

Image capturing apparatus

Image capturing apparatus automatically capturing sub image data

Image capturing apparatus capturing image and sub image data

A measles vaccine virus AIK-C strain comprises genomic RNA that produces by reverse transcription cDNA having a specific nucleotide sequence indicative of the viral genomic RNA in the seed virus for measles vaccine or measles virus vaccine. The complete sequence of 15,894 nucleotides has been determined.

Attenuated measles virus vaccine containing specific nucleotide sequence

Attenuated measles virus vaccine, containing specific nucleotide

A stabilized live attenuated vaccine with improved thermal stability, which comprises a live attenuated plain vaccine consisting of measles, mumps or rubella virus grown in a medium-199 for cell culture, or a combined live attenuated vaccine thereof, containing a stabilizing agent at a final concentration of lactose 2.5-5 W/V %, saccharose 2.5-5 W/V %, D-sorbitol 1.8-2 W/V %, sodium glutamate about 0.1 W/V % and gelatin hydrolyzate, M.W. approx. 35,000, 2-3 W/V %.

Stabilized live attenuated vaccine and its production

Growing community of inventors

Tokyo, Japan

Keiko Sasaki